0.80
Gossamer Bio Inc (GOSS) 最新ニュース
Charles Schwab Investment Management Inc. Raises Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World
Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch? - MSN
Cantor Fitzgerald Comments on Gossamer Bio FY2025 Earnings - Defense World
Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5? - Insider Monkey
Gossamer Bio Inc (NASDAQ: GOSS) Analysts Think Could Fell -290.62% From Current Levels - Stocks Register
Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts - Yahoo Finance
Gossamer Bio, Inc. (NASDAQ:GOSS) Position Decreased by Victory Capital Management Inc. - Defense World
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
10 Hot Biotech Stocks Under $5 - Insider Monkey
Q1 EPS Estimates for Gossamer Bio Reduced by HC Wainwright - Defense World
FY2028 EPS Forecast for Gossamer Bio Decreased by Analyst - Defense World
GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More - Nasdaq
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Gossamer Bio, $10 target - Investing.com
Wedbush Reiterates Outperform Rating for Gossamer Bio (NASDAQ:GOSS) - Defense World
Gossamer Bio Reports 2024 Financial Results and Progress - TipRanks
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Gossamer Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Gossamer Bio shares rise on Q4 earnings beat By Investing.com - Investing.com South Africa
Gossamer Bio shares rise on Q4 earnings beat - Investing.com India
Gossamer Bio Inc (GOSS) Q4 Earnings: EPS Loss of $0.15 Beats Est - GuruFocus.com
Gossamer Bio: Q4 Earnings Snapshot - mySA
Gossamer Bio earnings beat by $0.02, revenue topped estimates - Investing.com UK
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Bakersfield Californian
3 Promising Penny Stocks With Over $100M Market Cap - Simply Wall St
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) -March 07, 2025 at 05:47 pm EST - Marketscreener.com
Can Gossamer Bio's Latest Stock Options Package Attract Top Talent in Biotech? - Stock Titan
With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners - Yahoo Finance
Gossamer Bio (GOSS) Projected to Post Quarterly Earnings on Tuesday - Defense World
You Should Read This Analysis Before Investing in Gossamer Bio Inc (NASDAQ:GOSS) - US Post News
Gossamer Bio Inc (NASDAQ: GOSS) Up 11.11% This Year: What Is Going To Happen Next - Stocks Register
Gossamer Bio regains Nasdaq compliance with bid price - Investing.com
Gossamer Bio Is A Good Speculative 'Buy' On Seralutinib For PAH And PH-ILD (NASDAQ:GOSS) - Seeking Alpha
Understanding Gossamer Bio Inc Inc. (GOSS) Price Performance Through Chart Patterns - The InvestChronicle
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com
GOSS Stock Sees Surge of Approximately 15.18% in Last Five Days - Knox Daily
Gossamer Bio Inc (NASDAQ: GOSS) Stock Gained 1.83% Over A Month – Any Room To Run? - Marketing Sentinel
Gossamer Bio showcases seralutinib studies at PVRI Congress - MSN
Are Smart Investors Making the Right Decision? Gossamer Bio Inc (GOSS) - SETE News
Gossamer Bio Inc (GOSS) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Octagon Capital Advisors LP Increases Stake in Gossamer Bio Inc - GuruFocus.com
Real-Time Update: Gossamer Bio Inc (GOSS) Stock Navigates the Market with Up-to-Date Data - The News Heater
Investor’s Delight: Gossamer Bio Inc (GOSS) Closes Weak at 1.02, Down -0.97 - The Dwinnex
大文字化:
|
ボリューム (24 時間):